F S&P 500
5,532.50 -4.50 (-0.08%) F Dow Jones
39,436.00 -90.00 (-0.23%) F Nasdaq
19,978.00 +5.75 (+0.03%) E-mini Russell 2000 Index Futur
2,036.00 -8.90 (-0.44%) Petróleo
81.36 +0.53 (+0.66%) Oro
2,327.20 -3.60 (-0.15%)
Virbac SA (VIRP.PA)
Virbac SA
13e rue LID - BP 27
Carros 06511
France
33 4 92 08 71 00
https://corporate.virbac.com
Sector(es): Healthcare
Industria: Drug Manufacturers - General
Empleados a tiempo completo: 5,459
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Sebastien Huron | Chief Executive Officer | 673.42k | N/D | 1971 |
| Mr. Habib Ramdani | CFO & Deputy CEO | 344.22k | N/D | 1976 |
| Mr. Marc Bistuer | Deputy CEO and Director of Corporate Quality & Compliance | 328.54k | N/D | 1962 |
| Ms. Sandrine Brunel | Head of Corporate Communications | N/D | N/D | N/D |
| Ms. Nathalie Pollet | Head of Global Marketing & Market Development | N/D | N/D | N/D |
| Ms. Francesca Cortella | Head of Corporate Human Resources | N/D | N/D | N/D |
| Ms. Sophie Favini | Head of Global Business Operations | N/D | N/D | N/D |
| Mr. Bertrand Havrileck | Head of Corporate R&D | N/D | N/D | N/D |
| Mr. André Mathieu | Head of Global Industrial Operations, Supply Chain and Sourcing | N/D | N/D | N/D |
| Manuela Rodríguez | Director of Financial Projects | N/D | N/D | N/D |
Descripción
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Gestión corporativa
La calificación ISS Governance QuickScore de Virbac SA a partir del 1 de junio de 2024 es 8. Las puntuaciones principales son Auditoría: 10; Junta: 7; Derechos del accionista: 9; Compensación: 7.
